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Themitochondrionmaintains and regulates its prote-
ome with chaperones primarily inherited from its
bacterial endosymbiont ancestor. Among these
chaperones is the AAA+ unfoldase ClpX, an impor-
tant regulator of prokaryotic physiology with poorly
defined function in the eukaryotic mitochondrion.
We observed phenotypic similarity in S. cerevisiae
genetic interaction data between mitochondrial
ClpX (mtClpX) and genes contributing to heme
biosynthesis, an essential mitochondrial function.
Metabolomic analysis revealed that 5-aminolevulinic
acid (ALA), the first heme precursor, is 5-fold reduced
in yeast lackingmtClpX activity and that total heme is
reduced by half. mtClpX directly stimulates ALA
synthase in vitro by catalyzing incorporation of
its cofactor, pyridoxal phosphate. This activity is
conserved in mammalian homologs; additionally,
mtClpX depletion impairs vertebrate erythropoiesis,
which requires massive upregulation of heme
biosynthesis to supply hemoglobin. mtClpX, there-
fore, is a widely conserved stimulator of an essential
biosynthetic pathway and uses a previously unrec-
ognized mechanism for AAA+ unfoldases.INTRODUCTION
All organisms require AAA+ protein unfoldases to actively unfold
selected proteins for protein quality control and to regulate the
activity of specific substrates. The prokaryotic AAA+ unfoldase
ClpX is particularly specialized for regulatory unfolding, tuning
the proteome to respond to environmental stress and to orches-
trate changes in cell state (Gottesman, 2003; Sauer et al., 2004).
ClpX unfolds substrate proteins by ATP-driven translocation of
the polypeptide chain through the central pore of its hexameric
assembly. In complex with the ClpP peptidase, ClpX carries858 Cell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc.out protein degradation by translocating unfolded substrates
directly into the ClpP proteolytic chamber (Sauer et al., 2004).
ClpP degrades all known substrates of ClpX, although for a
few substrates, unfolding—not degradation—is the biologically
required event (Konieczny and Helinski, 1997; Mhammedi-
Alaoui et al., 1994).
In the eukaryotic cytoplasm, the 26S proteasome, which re-
tains the basic architecture of Clp family proteases as well as a
related AAA+ unfoldase component, functionally replaces the
Clp family proteases. The mitochondrion, however, maintains
an autonomous machinery for proteome remodeling, including
ClpX, that is largely conserved from its a-proteobacterial
ancestor (Figure S1). Mitochondrial ClpX (mtClpX) does not
contribute substantially to protein quality control (Rottgers
et al., 2002; van Dyck et al., 1998), suggesting that it may act pri-
marily to control the activities of its substrates by regulatory un-
folding and degradation, similarly to its prokaryotic homologs.
Mitochondrial ClpP (mtClpP) is not as widely conserved as
mtClpX, and mtClpX in organisms without ClpP lacks the ClpP
interaction motif (Figure S1), suggesting that mtClpX may
execute a protease-independent function. The specific contribu-
tions of mtClpX to mitochondrial physiology, however, are not
well understood. mtClpX is required to initiate the mitochondrial
unfolded protein response (Haynes et al., 2010) and has been
observed to affect mitochondrial nucleoid morphology (Bogen-
hagen et al., 2008; Kasashima et al., 2012), but its mechanism
in these roles is unknown. The single physiological substrate
identified for mtClpX, the GTPase Noa1, is degraded by
mtClpXP, but how this degradation contributes to Noa1 mainte-
nance or regulation in vivo is unclear (Al-Furoukh et al., 2014).
To uncover the physiological functions and partners of
mtClpX, we mined previously generated large-scale genetic
and chemical interaction maps in S. cerevisiae (Costanzo et al.,
2010; Hoppins et al., 2011; Lee et al., 2014). We observed strong
links between the yeastmtClpX gene (MCX1) and genes involved
in the first steps of heme biosynthesis (Figure 1A), suggesting
that mtClpX might act during heme biosynthesis as well.
Nearly all organisms (with a few known exceptions among
parasites) require heme for viability (Koreny´ et al., 2012), and
most organisms synthesize heme endogenously. Heme is an
AB
Figure 1. MCX1 Interacts Chemically and
Genetically with the Heme Biosynthetic
Pathway
(A) The metabolic pathway for the first step of
heme biosynthesis in non-plant eukaryotes. The
genetic and chemical interaction profile ofMCX1 is
highly correlated with the profiles of yeast genes
(HEM25,HEM1, and HEM2, shown in red) involved
in the first steps of heme biosynthesis. Dashed
lines indicate uncertainty in assigning Hem25 to
glycine uptake or ALA export. Gray bars indicate
mitochondrial membranes. CoA, coenzyme A.
(B) MCX1, HEM1, and HEM25 alleles exhibit syn-
thetic phenotypes. 5-fold serial dilutions from cell
suspensions with optical density 600 (OD600) = 1
were pinned on YP (1% yeast extract, 2%
peptone) + 2% agar, with 2% glucose or 3%
glycerol. ALA in ‘‘glycerol + ALA’’ indicates
50 mg/ml ALA. Growth on glucose after 2 days and
on glycerol after 3 days is shown. wt, wild-type.
See also Figure S1.essential cofactor for many enzymes, including several mem-
bers of the respiratory chain, p450 enzymes, and sterol biosyn-
thetic enzymes, and also acts as the sensor component of
multiple environmentally responsive transcription factors (Gir-
van and Munro, 2013; Hamza and Dailey, 2012). In non-plant
eukaryotes, the first, rate-limiting step of heme biosynthesis is
carried out in the mitochondrial matrix, and its product, 5-ami-
nolevulinic acid (ALA), is exported to the cytoplasm (Figure 1A).
After several further biosynthetic steps, a heme precursor is re-
imported into the mitochondrion, where synthesis is completed
(Hamza and Dailey, 2012). Cells tightly control heme biosyn-
thesis to meet demand; overstimulation of heme biosynthesis
drains valuable central metabolites and can cause damage
from reactive unliganded heme or accumulation of toxic heme
precursors, whereas insufficient heme production limits the ac-
tivity of the diverse proteins that require it as a cofactor (Girvan
and Munro, 2013; Hamza and Dailey, 2012). As a consequence,
causative human disease alleles of every enzyme in hemeCell 161, 858biosynthesis have been identified (Cama-
schella, 2009; Sassa, 2006).
In this study, we discover a stimulatory
function for mtClpX in heme biosynthesis.
Comparison of metabolite levels in wild-
type and mcx1D cell extracts indicated
that MCX1 acts to promote ALA synthe-
sis, the initial step of heme biosynthesis.
Mcx1 directly activates the enzyme that
performs this step, ALA synthase (ALAS,
Hem1 in yeast), by accelerating binding
of the cofactor pyridoxal phosphate
(PLP) to apoenzyme. This activation is
conserved for mammalian homologs of
these enzymes and proceeds without
degradation by mtClpP. mtClpX, there-
fore, stimulates an essential biosynthetic
process through a previously unrecog-
nized activity for AAA+ unfoldases: accel-erating cofactor insertion into its protein substrate. Finally, we
find that vertebrate erythropoiesis is impaired by mtClpX knock-
down, commensurate with a central, conserved role for mtClpX
in heme production.
RESULTS
MCX1 Promotes Heme Biosynthesis
Using S. cerevisae genetic (Costanzo et al., 2010; Hoppins et al.,
2011) and chemical (Lee et al., 2014) interaction data, we
searched for genes with interaction profiles similar to that of
MCX1, the yeast gene encoding mtClpX (van Dyck et al.,
1998). Because S. cerevisiae (like several other fungi), lacks a
ClpP homolog, yeast Mcx1 likely acts purely as a protein unfol-
dase, without coupled degradation of its substrates. MCX1
was strongly correlated (Costanzo et al., 2010; Hoppins et al.,
2011; Lee et al., 2014) with several genes involved in the early
steps in heme biosynthesis: HEM1, the gene encoding ALAS–867, May 7, 2015 ª2015 Elsevier Inc. 859
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Figure 2. Mcx1 Promotes Heme Biosyn-
thesis at the Step of ALA Synthesis
(A) Total porphyrin levels were measured by fluo-
rescence in oxalic acid cell extracts (excitation,
400 nm; emission, 662 nm); p < 0.001 for difference
between wild (wt) and MCX1 mutants. +ALA in-
dicates supplementation of growth medium with
50 mg/ml ALA.
(B) Metabolites involved in the first step of heme
biosynthesis (KG, a-ketoglutarate; SA, succinic
acid; GLY, glycine; GLX, glyoxylate; SER, serine)
were measured in extracts of the indicated yeast
strains by LC-MS. p < 0.001 for ALA perturbation in
mcx1D cells.
(C) ALA levels in cell extracts were measured using
modified Ehrlich’s reagent. p % 105 for ALA
reduction in MCX1 and HEM1 mutants.
(D) Mcx1 was isolated with a-FLAG antibody-
conjugated beads from cells harboring HEM1-
3xMYC and MCX1-3xFLAG (wild-type [WT] or
Mcx1EQ [EQ]) or untaggedMcx1 []) alleles at the genomic loci and eluted with 3xFLAG peptide. The eluate was analyzed by western blot for Mcx1 (a-FLAG) and
Hem1 (a-Myc). The image below the label ‘‘IP a-FLAG’’ represents the proteins that were immunoprecipitated with an anti-FLAG antibody.
(E) Cellular levels of Hem1-3xMyc were analyzed by western blot, using alkaline cell extracts (von der Haar, 2007). Hem1-3xMyc intensity: in mcx1D, 1.1 ± 0.1,
relative to wild-type, p = 0.35 for difference; in hem1-DAmP, 0.3 ± 0.1, p = 0.01. The mitochondrial protein Por1 was probed as a loading control.
Error bars represent mean ± SD. See also Extended Experimental Procedures and Figure S2.(EC 2.3.1.37) (Arrese et al., 1983); HEM25, encoding the putative
mitochondrial glycine/ALA transporter SLC25A38 (Guernsey
et al., 2009); andHEM2, encoding the cytosolic enzyme that cat-
alyzes the second step in heme biosynthesis, ALA dehydratase
(ALAD; EC 4.2.1.24) (Gollub et al., 1977; Figure 1A).
We tested the growth of MCX1, HEM1, and HEM25 mutants
singly and in combination on fermentable (glucose) or mitochon-
drial respiration-requiring (glycerol) carbon sources (Figure 1B).
MCX1 deletion or mutation to an ATP hydrolysis-blocked allele
(mutation E206Q in the Walker B motif, mcx1EQ) did not impair
fermentative or respiratory growth. A mutation in the essential
geneHEM1 corresponding to a sideroblastic anemia allele of hu-
man ALAS (G351R in human ALAS2 [Wintrobe and Greer, 2004],
G275R in yeast HEM1) also showed normal fermentative and
respiratory growth but was lethal in combination with mcx1D
(Figure 1B). In combination with the deletion of HEM25, MCX1
deletion or mutation dramatically impaired or abrogated mito-
chondrial respiration (Figure 1B). Respiratory growth of mcx1D
hem25D, andmcx1D hem1G275R was restored by supplementa-
tion with ALA, indicating that the synthetic phenotypes of Mcx1
resulted from a deficiency at the mitochondrial first step in heme
biosynthesis. These strong synthetic phenotypes suggest an
important role for Mcx1 in heme biosynthesis.
To directly test the contribution of MCX1 to heme biosyn-
thesis, we measured heme levels in logarithmically growing
yeast by total porphyrin fluorescence and by 55Fe incorporation.
Both measurements indicated a 2- and a 3-fold reduction of
heme in mcx1D and mcx1EQ yeast, respectively (Figure 2A; Fig-
ure S2A). Mirroring the severity of its respiratory growth pheno-
type, mcx1D hem25D yeast (Figure S2B) exhibited a greater
heme deficiency than MCX1 mutant yeast. Supplementing the
growth medium with ALA rescued the poor heme production of
MCX1 mutants (Figure 2A). This rescue strongly suggests that
Mcx1 promotes the first phase of heme biosynthesis: synthesis
and export of ALA.860 Cell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc.Mcx1 Stimulates ALA Synthesis, the First Step of Heme
Biosynthesis
To determine the specific perturbation leading to heme defi-
ciency in cells lacking MCX1, we monitored total metabolites
in extracts from wild-type and mcx1D yeast by liquid chroma-
tography-mass spectrometry (LC-MS). Because MCX1-corre-
lated genes function early in heme biosynthesis, we focused
on metabolites directly involved in the first mitochondrial phase
(Figure 1A). Ion intensities detected for metabolites preceding
ALA synthesis (a-ketoglutarate, succinate, glycine, glyoxylate,
and serine) were equivalent in wild-type and mcx1D extracts.
In contrast, the ion intensity for ALA was reduced more than
80% in mcx1D extracts (Figure 2B). Chemical detection of
ALA in extracts corroborated this reduction (Figure 2C).
mcx1D extracts exhibited 75% reduced ALA in this assay,
and mcx1EQ extracts had an enhanced defect (85% reduc-
tion) (Figure 2C). For comparison, a reduced expression allele
of Hem1 (hem1-DAmP) (Schuldiner et al., 2005) caused an
80% reduction in cellular ALA. Thus, we conclude that Mcx1
activity promotes heme production at the first step of ALA
synthesis.
Mcx1 Interacts Directly with the ALAS Hem1
We hypothesized that the Mcx1 unfoldase could act directly on
Hem1 (the yeast ALAS) to promote ALA synthesis. ALAS is the
rate-limiting enzyme for heme biosynthesis in nearly all cell types
(Hamza and Dailey, 2012) and, as such, would be a likely target
for a stimulatory factor in heme biosynthesis. To test for physical
interaction between Mcx1 and Hem1, we affinity purified Mcx1-
3xFLAG and Mcx1EQ-3xFLAG from yeast cell extracts and
probed for copurifying Hem1-3xMyc (Figure 2D). We detected
Hem1 in Mcx1EQ but not wild-type Mcx1 purified samples,
consistent with the ATP dependence of ClpX-substrate interac-
tions. These data suggest that Hem1 is a direct substrate for the
Mcx1 unfoldase.
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Figure 3. Mcx1 Accelerates Incorporation of PLP Cofactor
into Hem1
(A) Rate of apoHem1 activation by PLP. apoHem1 (3 mM) was incubated with
PLP (50 mM) and ATP (2 mM), with (orange) or without Mcx1 (2 mM hexamer)
(blue), and assayed for ALAS activity at indicated times using modified Ehr-
lich’s reagent. t, time.
(B) ALAS activity resulting from 4 min incubation of apoHem1 ±Mcx1, with or
without ATP, assayed as in (A). p < 0.0001 for stimulation by Mcx1 + ATP.
(C) PLP binding to apoHem1 was monitored by pyridoxyllysine fluorescence
(excitation, 434 nm; emission, 515 nm).
(D) Rates of PLP binding to apoHem1 determined by linear fits to fluorescence
increase between 100 s and 200 s in (C). p < 0.0001 for stimulation by Mcx1.
Error bars represent mean ± SD.
See also Figure S3.To increase ALA production by acting on Hem1, Mcx1 might
increase Hem1 protein abundance or might stimulate the activity
of Hem1. Multiple mechanisms for control of ALAS abundance
have been characterized (Hamza and Dailey, 2012; Tian et al.,
2011). If Mcx1 is required to maintain Hem1 protein levels,
decreased Hem1 would be expected inmcx1D cells. Hem1 pro-
tein abundance was equivalent in wild-type and mcx1D lysates
(Figure 2E). In contrast, Hem1 reduction in a hem1-DAmP strain
was easily detected (Figure 2E).
To test whetherMcx1 acts by increasing the enzymatic activity
of Hem1, we purified these proteins and tested the effect of
Mcx1 on the catalytic activity of Hem1. In contrast to the large
reduction in ALA in mcx1D cells, Mcx1 had little effect on the
rate of ALA production by Hem1 in vitro (Figure S3), leading us
to consider mechanisms by which Mcx1 might stimulate Hem1
activity other than a straightforward effect on Vmax.
Mcx1 Activates Hem1 by Stimulating Insertion of Its
Cofactor
Hem1 (like all ALASs) is part of a large, evolutionarily related
enzyme family that depends on the cofactor PLP for activity(the a-family of PLP-dependent enzymes) (Eliot and Kirsch,
2004). PLP binds covalently to an active-site lysine but requires
other contacts buried in the interface of the homodimeric
enzyme for stable binding (Astner et al., 2005; Gong et al.,
1996). We hypothesized that Mcx1 might stimulate formation
of the PLP-loaded holoenzyme. To test this idea, we prepared
PLP-free Hem1 (apoHem1) and monitored enzyme activity
after the addition of PLP. As reported previously (Volland
and Felix, 1984), apoHem1 regained activity slowly on its
own (0.73%/min) (Figure 3A). Inclusion of Mcx1 accelerated
apoHem1 activation by a factor of ten (Figure 3A). Acceleration
by Mcx1 depended on ATP, as expected if Mcx1 acts by remod-
eling or unfolding Hem1 (Figure 3B). We directly measured PLP
binding to apoHem1 by monitoring the formation of the fluores-
cent pyridoxyllysine bond. The rate of PLP binding for apoHem1
alone (1.0%/min) (Figure 3C) closely matched the rate of activa-
tion for apoHem1 alone (Figure 3A). Mcx1 stimulated PLP bind-
ing by a factor of eight (7.6%/min), and this stimulation was also
dependent on ATP (Figures 3C and 3D). Thus, Mcx1 accelerates
formation of active Hem1 by stimulating cofactor binding to the
apoenzyme.
We expect that, to efficiently activate apoHem1 in mitochon-
dria, Mcx1 would interact preferentially with apoHem1 over
holoHem1. Using purified proteins, we monitored the interaction
of Mcx1-3xFLAGwith apo- and holoHem1 by coimmunoprecipi-
tation. We observed more efficient interaction of purified Hem1
with ATP-locked Mcx1 (Mcx1EQ) than with wild-type Mcx1 (Fig-
ures 4B and 4C), consistent with the interaction observed be-
tween Hem1 and ATP-locked Mcx1 in cell extracts. Notably,
we observed a 10-fold greater amount ofMcx1-bound apoHem1
than holoHem1 (Figures 4B and 4C), indicating that Mcx1 has
intrinsic binding specificity for the species of Hem1 that it
stimulates.
Mcx1 Activates Hem1 by Acting as an Unfoldase
Most activities characterized for AAA+ unfoldases involve com-
plete or large-scale unfolding of their substrates. Because the
folded context of the ALAS active site is important for PLP bind-
ing, Mcx1 is unlikely to globally unfold the enzyme to activate it.
Therefore, we sought to determine whether Mcx1 acts as an un-
foldase to activate Hem1 or whether it might use an alternative
mechanism. To unfold their substrates, AAA+ unfoldases trans-
locate the substrate polyptide through the hexamer pore by the
ATP-powered movement of several loops within the pore (Fig-
ure 4A; Figure S1) To test whether activating Hem1 requires
the unfolding machinery of Mcx1, we introduced mutations into
these loops at the genomic locus. The central loop (pore-1) is
essential for gripping and translocating polypeptides through
the pore of the hexamer; we mutated the invariant tyrosine
(mcx1Y174A) within this highly conserved sequence, an alteration
that abrogates the unfolding activity of many AAA+ unfoldases,
including ClpX (Siddiqui et al., 2004). The RKH and pore-2 loops
contribute to, but are less critical for, unfolding. They are more
important for substrate selection, and their sequences diverge
widely across evolution (Martin et al., 2008a) (Figure S1). We re-
placed the RKH or pore-2 loops with the highly divergent E. coli
sequences (mcx1E.c.RKH or mcx1E.c.pore2; Figure S1; Table S1),
a substitution that was previously demonstrated to transplantCell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc. 861
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Figure 4. Mcx1 Requires the ClpX Translocating Pore Loops to
Activate Hem1 and Promote ALA Production
(A) Left: pore loops are highlighted on a cross-section diagram of a ClpX
hexamer. RKH loops are shown in yellow, pore-1 loops are in dark orange, and
pore-2 loops are in blue. Right: ALA levels in cell extracts were measured by
modified Ehrlich’s reagent and normalized to wild-type (wt). Cells harbored
indicated mutations at the genomicMCX1 locus. p < 0.0001 for ALA reduction
in all MCX1 mutants.
(B) Co-immuoprecipitation of apo- and holoHem1 with Mcx1-3xFLAG variants
was tested, using purified proteins. Proteins were separated by SDS-PAGE
and stained with Sypro Orange. Lower panel, ‘‘Hem1 (rescaled),’’ showsHem1
bands rescaled to maximum Hem1 intensity. Mcx1 variants are indicated as
follows: wt, wild-type; EQ, Walker B E206Q; and YA, pore-1 Y174A.
(C) Quantitation of Hem1 intensities in (B), normalized to Mcx1-apoHem1
coimmunoprecipitation. p < 0.001 for more apoHem1 than holoHem1 bound
by each Mcx1 variant. apo, apoHem1; holo, holoHem1.
(D) ALAS activity resulting from 4 min incubation of apoHem1 (apo) with 50 mM
PLP ±Mcx1Y174A, ± ATP, assayed as in Figure 3A. p < 0.05 for suppression of
Hem1 by Mcx1Y174A both with and without ATP. coIP, co-immunoprecipita-
tion. Error bars represent mean ± SD.
See also Figure S1.E. coli ClpX substrate specificity to human mtClpX (Martin et al.,
2008a). To determine the ability of these variant enzymes to acti-
vate Hem1, we monitored ALA levels within the corresponding
MCX1 mutant strains. All pore loop mutants had reduced ALA,
and the magnitude of reduction correlated with the importance
of the pore loop to translocation (Figure 4A). The pore-1mutation
caused a more severe ALA deficiency than MCX1 deletion, and
substitution with E. coli RKH or pore-2 loops caused a milder862 Cell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc.ALA deficiency than MCX1 deletion. mcx1Y174A also exhibited
genetic interactions similar to those of mcx1D (Figure 1B).
To further probe the contribution of the ClpX translocation
machinery to ALA synthesis, we tested the activity of purified
Mcx1Y174A in vitro. As observed previously for E. coli ClpX (Mar-
tin et al., 2008b), Mcx1Y174A has mildly elevated ATPase activity
(368 ± 55 ATP per hexamer per minute, compared to 219 ± 23
ATP per hexamer per minute for wild-type), indicating that
Mcx1Y174A phenotypes do not result from loss of ATPase activity.
Because Mcx1 pore loops might bind unstructured elements of
Hem1, ALA reduction in Mcx1 pore loop mutants could be due
to a defect in binding Hem1 rather than unfolding. To test
Mcx1Y174A substrate binding, we monitored the interaction of
Hem1 with Mcx1Y174A by coimmunoprecipitation using purified
proteins. We observed that Hem1 interacted with equivalent
strength to Mcx1Y174A and wild-type Mcx1 and also was selec-
tive for the apoenzyme by an order of magnitude (Figures 4B
and 4C). Therefore, mutation of the essential translocating
ClpX pore loop-1 does not abolish Mcx1 stimulation of Hem1
by disrupting complex formation. Having excluded an interaction
defect, we tested the effect of Mcx1Y174A on PLP activation of
apoHem1 in vitro. Mcx1Y174A mildly suppressed apoHem1 acti-
vation (Figure 4D; compare to Figure 3B for stimulation byMcx1),
suggesting that nonproductive interactions of translocation-
blockedMcx1 with Hem1 interfere with Hem1 spontaneous acti-
vation. These data strongly indicate that Mcx1 activates Hem1
using the central polypeptide translocating activity of ClpX
homologs.
mtClpX Activation of ALAS Is Conserved in Metazoans
Sequence conservation is high between fungal and metazoan
ALAS andmtClpX, suggesting that activation of ALAS bymtClpX
may be conserved. Wemeasured the effect of mouse mtClpX on
PLP activation of human erythroid ALAS (ALAS2) apoenzyme
in vitro. mtClpX stimulated apoALAS2 activation approximately
2.5-fold (Figure 5A); this activation required the presence of
ATP (Figure S4). mtClpX activation of ALAS, therefore, is broadly
conserved among eukaryotes.
Although S. cerevisisae lacks a ClpP homolog, mtClpP is pre-
sent in most other eukaryotes. Because the effect of mtClpX on
ALAS is activating, the presence of a mtClpP protease might
oppose this action of mtClpX. Therefore, we wanted to deter-
mine whether mtClpP interferes with this activation by coupled
degradation. In the presence of mtClpP, mtClpX still stimulated
PLP activation of apoALAS2, but the magnitude of this stimula-
tion was reduced (Figure 5A). We monitored possible apoALAS2
degradation during incubation withmtClpXP and ATP. No degra-
dation of apoALAS2 was observed over 30 min (Figures 5B and
5C), although mtClpXP efficiently degraded casein (a model
substrate for mtClpXP) (Kang et al., 2002) under the same
conditions.
We considered whether mtClpP might suppress mtClpX acti-
vation of apoALAS2 by suppressing mtClpX ATPase activity.
Prokaryotic ClpP partially suppresses the ATPase of prokaryotic
ClpX (Kim et al., 2001). If present in the mitochondrial enzymes,
ATPase suppression could explain the lower stimulation of
ALAS2 by mtClpX when mtClpP is present. In the presence of
mtClpP, we observed an30%–40%suppression of themtClpX
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Figure 5. Mammalian mtClpX Stimulates PLP Activation of
apoALAS2 and Does Not Direct apoALAS2 for Degradation by
mtClpP
(A) apoALAS2 activation by PLP in vitro. Recombinant human apoALAS2
(5 mM) was incubated with PLP, with mouse mtClpX (2 mM hexamer) and hu-
man mtClpP (3 mM 14-mer) as indicated, and activation between 4 and 10 min
was measured by an NAD-coupled assay. p < 0.01 for acceleration of
apoALAS2 activation by mtClpX, and p < 0.05 for acceleration by mtClpXP.
(B and C) mtClpXP degradation test. apoALAS2 or a-casein (5 mM each) were
incubated with mouse mtClpX (0.3 mM hexamer), human mtClpP (0.8 mM 14-
mer), and ATP regenerating system (including 4mMATP, except where noted)
at 30C, and aliquots were withdrawn and quenched with SDS at indicated
time points. Proteins were separated by SDS-PAGE and stained with Sypro
Orange. Quantitation of degradation is shown in (B), and gel is shown in (C).
(D) MousemtClpX (0.3 mMhexamer) ATPase activity wasmonitored by NADH-
coupled assay, in the presence of human mtClpP (0.8 mM 14-mer) and
apoALAS2 (apoA2, 10 mM) as indicated. p < 0.01 for suppression of ATPase by
mtClpP, and p < 0.05 for stimulation of ATPase by apoALAS2.
Error bars represent mean ± SD. See also Figure S4.ATPase rate (Figure 5D). This effect is commensurate with the
magnitude of suppression of ALAS2 activation and could, there-
fore, account for reduced activation by mtClpXP without
invoking protein degradation. We did not observe strong stimu-
lation of mtClpX ATPase (either basal or ClpP suppressed) by
ALAS2 (Figure 5D). Stimulation of ClpX ATPase by its substrates
is common but highly variable and is less apparent for substrates
that are more resistant to unfolding (Burton et al., 2003; Kennis-
ton et al., 2003).mtClpX Is Required for Efficient Erythropoiesis
In organisms with circulating blood cells, heme biosynthesis is
massively upregulated during erythropoiesis to meet demand
from hemoglobin production (Hamza and Dailey, 2012). Defects
in heme biosynthesis cause several human anemias; congenital
sideroblastic anemia is caused most commonly by mutations in
ALAS2, the erythroid-specific ALA synthase (Camaschella,
2009). Because mtClpX activates ALAS, we reasoned that it
would be crucial for erythropoiesis. To facilitate increased
heme production during erythropoiesis, heme biosynthetic
genes are transcriptionally upregulated. We examined a previ-
ously published genome-wide transcriptional dataset for human
hematopoiesis (Novershtern et al., 2011) and observed that
mRNA levels of CLPX, but not CLPP, were upregulated during
erythropoiesis (Figure 6A). We also observed upregulation of
Clpx during erythroid maturation in Friend mouse erythroleuke-
mia (MEL) cells (Figure S5A). These data suggest that CLPX con-
tributes to erythropoiesis. In addition, upregulation of CLPX, but
notCLPP, suggests that in this cell type, increased CLPX relative
toCLPPmay help to avoidCLPP suppression of ALASactivation.
To examine the contribution of mtClpX to red blood cell devel-
opment, we performed morpholino-mediated knockdowns in
D. rerio. Zebrafish encode two homologs of mtClpX, clpxa and
clpxb. Expression of both clpxa and clpxb is ubiquitous
throughout the embryo (Figure S5B), indicating thatmtClpX func-
tion is likely not restricted to developing red blood cells. clpxa
mRNAwas specifically reduced by two independent morpholino
sequences (Figure S5C; Table S2); both morpholinos resulted in
morphologically normal embryos with reduced hemoglobin
staining by o-dianisidine, indicating a specific defect in red blood
cell development (Figure 6B). Morpholinos targeting clpxb
caused toxicity without specific mRNA reduction, preventing
further phenotypic analysis. To quantify the anemia we observed
in clpxa knockdown embyros, we performed flow cytometry of
dissociated cells from embryoswith GFP-marked erythroid cells;
clpxa knockdown embryos from both morpholinos exhibited an
50% reduction in GFP-positive cells at 72 hr post-fertilization
(hpf) (Figure 6C). We also observed a reduction in early erythroid
precursors at 24 hpf (Figure S5F), which may result from reduc-
tion in non-erythroid heme production from ALAS1 (Okano
et al., 2010). ALAS1 shares very high sequence identity with the
erythroid-specific ALAS2, aswell aswith yeast ALAS, and is likely
subject to the same stimulatory activity by mtClpX. Supplemen-
tation with ALA starting at 24 hpf fully rescued clpxa knockdown-
induced anemia (Figure 6D). ALA supplementation specifically
rescued anemia in ALAS2 mutant embryos (sauternes; Brownlie
et al., 1998), but not anemia in mitochondrial iron transporter
(MFRN1, SLC25A37) mutants (frascati; Shaw et al., 2006) (Fig-
ure 6E). These results demonstrate that ALA specifically rescues
defects in ALA synthesis and not defects in later steps in heme
biosynthesis. Therefore, mtClpX stimulation of ALA synthesis is
conserved from S. cerevisae to vertebrates and is important for
efficient heme synthesis during erythropoiesis.
DISCUSSION
In this work, we used large-scale genetic interaction data
coupled with metabolic analysis to uncover a broadly conservedCell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc. 863
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Figure 6. mtClpX Is Important for Vertebrate HemeBiosynthesis and
Erythropoiesis
(A) RelativemRNA abundance for humanCLPX,CLPP,ALAS2, andSLC25A38
(indicated as S25A38) throughout erythropoiesis, as indicated in a microarray
dataset described in Novershtern et al. (2011). Erythroid development stages
were defined by cell-type-specific markers as follows: 1, CD34+ CD71+
GlyA; 2, CD34CD71+GlyA; 3, CD34CD71+GlyA+; 4, CD34CD71low
GlyA+; 5, CD34 CD71 GlyA+.
(B) o-dianisidine staining (brown) for hemoglobinized red cells in zebrafish em-
byos. Embyros were grown from zygotes injected at the one- to two-cell stage
withclpxa-targetingmorpholinos (MOaandMOb)oruninjectedzygotes (control).
(C) Erythrocyte development at 72 hpf was quantified by flow cytometry, using
dissociated cells from Tg(globin-LCR:eGFP) zebrafish. p % 0.01 for erythro-
cyte reduction by clpxa knockdown with either morpholino.
(D) Rescue of clpxaMOb-induced anemia by ALA supplementation. Tg(globin-
LCR:eGFP) zebrafish embryos were supplemented with 2 mM ALA from 24
to 72 hpf, upon which GFP+ erythrocytes were quantified by flow cytometry.
p = 0.025 for rescue of anemia in clpxa knockdown embryos by ALA
supplementation.
(E) Heterozygous sauternes (ALAS2 mutant) or frascati (SLC25A37 mutant)
zebrafish were crossed, and progeny were grown for 72 hpf, with or without
ALA supplementation as in (D). Anemia was assayed by o-dianisidine staining.
p = 0.04 for rescue of anemia in sauternes+/ progeny by ALA. n = 52 for
sauternes ALA; n = 43 for sauternes +ALA; n = 98 for frascati ALA; n = 122
for frascati +ALA.
Error bars represent mean ± SD. See also Figure S5.
864 Cell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc.stimulatory activity of mtClpX in the essential biological process
of heme biosynthesis. Our biochemical studies revealed that
mtClpX specifically activates the apoenzyme form of ALAS, the
first enzyme in heme biosynthesis, by accelerating binding to
the cofactor PLP. mtClpX activation of ALAS is not coupled to
degradation bymtClpP, although the presence of mtClpP results
in partial inhibition. Consistent with its function in heme biosyn-
thesis, mtClpX is important during erythropoiesis, when heme
is in extreme demand as a ligand for hemoglobin. mtClpX may
represent a new factor to consider in the etiology and treatment
of disorders of heme biosynthesis.
Whymight ALAS need a chaperone for PLP insertion? The free
PLP cofactor is highly reactive and is maintained at a low con-
centration in the cell, near or below the dissociation constant
for binding to many PLP-dependent enzymes (Cheung et al.,
2003; Hamfelt, 1967). The very slow dissociation rate of PLP
from its covalent attachment in active sites allows complex for-
mation under these conditions, but spontaneous holoenzyme
formation is likely to be inefficient. Therefore, activemechanisms
for conjugation of PLP with apoenzymes have long been postu-
lated. For example, pyridoxal kinase can interact with somePLP-
dependent enzymes to shuttle newly generated PLP into the
active sites of these enzymes in vitro (Cheung et al., 2003; Kim
et al., 1988), but it is not known whether this is a general mech-
anism used in vivo. There is no known pyridoxal kinase activity in
the mitochondrion, which suggests that a different mechanism
(such as the one described here for ALAS) might be needed to
facilitate PLP conjugation within this organelle. Determining
whether mtClpX acts more broadly among mitochondrial PLP-
dependent enzymes to facilitate PLP binding, or exclusively on
ALAS, will be important to our understanding of the maturation
and function of this large and important class of enzymes.
The Hsp70/90 chaperone system actively promotes ligand
binding for several other classes of proteins, the best studied
of which is the glucocorticoid receptor (Kirschke et al., 2014;
Pratt et al., 2008). The Hsp70/90 enzymes modulate the struc-
ture of their substrates by a different mechanism than AAA+
unfoldases. Hsp70 and Hsp90 bind to partially unfolded interme-
diate structures, and the ATPase cycle does not appear coupled
to an unfolding power stroke like that described for AAA+ unfol-
dases (Russell andMatouschek, 2014; Saibil, 2013). The require-
ment for a AAA+ unfoldase for apoALAS activation suggests a
fundamentally different mechanism for facilitating ligand inser-
tion, which may be dictated by the structural features of the
substrate. In contrast to the structurally unstable and aggrega-
tion-prone unliganded glucocorticoid receptor (Kirschke et al.,
2014), both apo- and holoALAS are well-structured dimers.
This difference in the structure and folding of the substrate pro-
teins could explain a requirement for directed unfolding by a
AAA+ unfoldase rather than trapping of partially unfolded inter-
mediates by Hsp70/90 to accelerate PLP binding.
How does mtClpX accelerate PLP binding to ALAS? Multiple
residues within the folded active site of ALAS form important
contacts with PLP, and studies of the prototypical a-family
PLP enzyme, aspartate aminotransferase, revealed that PLP is
lost upon enzyme unfolding (Astner et al., 2005; Gong et al.,
1996; Wu et al., 2003). Because mitochondrial proteins are
unfolded by the mitochondrial translocation machinery during
partial unfoldingimport into
matrix inactive
active for
heme
synthesis
Figure 7. Model for mtClpX Activation of ALAS
ALAS is unfolded by the mitochondrial import machinery and refolds in the
mitochondrial matrix. Newly folded ALAS binds PLP slowly on its own; partial
unfolding by mtClpX renders the active site of ALAS more accessible to PLP,
thus accelerating holoenzyme formation.Mitochondrial importmachinery (light
gray), ALAS (dark gray), mtClpX (purple), and PLP (green) are diagrammed.import, newly imported and refolded ALAS is likely in the apo
state. mtClpX is unlikely to extensively re-unfold ALAS as part
of its activation mechanism, as this action would return the
enzyme to a non-PLP binding form, although it is possible that
the directionality or rate of mtClpX-mediated complete unfolding
could promote refolding through a PLP-binding intermediate.
One attractive model is that mtClpX locally unfolds or distorts
the structure of ALAS to expose the buried active site and pro-
mote efficient PLP binding (Figure 7). The strong preference
mtClpX exhibits for binding apoHem1 indicates that it must spe-
cifically recognize a structural feature or exposed motif that is
specific to the apoenzyme to initiate this activity. Two distantly
related AAA+ ATPases that function as dedicated activators for
red- or green-type Rubisco stimulate a reverse event, a release
of an inhibitory ligand (Mueller-Cajar et al., 2011; Wang and Por-
tis, 1992). The better characterized red-type activase has been
proposed to trigger ligand release by partial unfolding of Rubisco
(Mueller-Cajar et al., 2011; Wang and Portis, 1992). Although
stimulating ligand release and stimulating cofactor association
are reverse biological processes, they may be mechanistically
related. It will be interesting to compare the characteristics of
the unfoldase-induced structural alterations in these distantly
related systems.
A limited-unfolding model for ALAS activation by ClpX is
consistent with the lack of ALAS degradation by mtClpXP. If un-
folding by mtClpX is sufficiently limited, then the substrate pro-
tein would never be translocated far enough through the
mtClpXP complex to reach the proteolytic active sites within
the chamber of mtClpP. Because substrates of protease-
coupled AAA+ unfoldases are often identified or validated by
their degradation, such unfolding without coupled degradation
may be a much more widespread activity than indicated by the
repertoire of known substrates.
How does ClpX discriminate between activation and degrada-
tion? ClpX is best understood as part of the ClpXP proteolytic
machine, and all previously identified substrates of ClpX are sub-
ject to degradation by ClpP. For two substrates, the tetrameric
MuA transposase and the dimeric plasmid replication factor
TrfA, unfolding rather than degradation is the biologically crucial
event, although both substrates can be degraded by ClpXP (Ko-
nieczny and Helinski, 1997; Mhammedi-Alaoui et al., 1994). The
function of ClpX in these cases is to extract one subunit from
the complex by complete unfolding, altering the conformationof the remaining protein(s); the subsequent degradation by
ClpP of the unfolded subunit, therefore, is not deleterious. In
the case of ALAS, where the dimer must remain intact to func-
tion, ClpX must instead activate the specific molecule upon
which it exerts force. Therefore, proteolysis by ClpP must not
occur; this ClpP-independent action of ClpX is what we observe.
Within the context of the cell, AAA+ unfoldasesmight be spec-
ified for nonproteolytic functions by sublocalization or interaction
with other binding partners that is mutually exclusive with bind-
ing to their cognate protease. For example, yeast mtClpX asso-
ciates tightly with the mitochondrial inner membrane (van Dyck
et al., 1998); this association might sterically block mtClpP asso-
ciation in the eukaryotes that encode it as well as facilitate effi-
cient activation of ALAS newly imported across the membrane.
Such complete biochemical uncoupling of substrate unfolding
from proteolysis has not been previously observed for any prote-
ase-coupled AAA+ unfoldase, but two recently described activ-
ities of AAA+ proteases are informative for how this may be
accomplished. TheC. crescentusDNApolymerase clamp loader
subunit (DnaX) is partially degraded by ClpXP to produce a func-
tional isoform (Vass and Chien, 2013). To trigger N-end rule sub-
strate delivery to ClpAP from the E. coli adaptor protein ClpS, the
ClpA translocation pore engages ClpS itself without causing
ClpS degradation (Rivera-Rivera et al., 2014; Roma´n-Herna´ndez
et al., 2011). In these cases, local structure that is highly resistant
to unfolding (in the case of DnaX and ClpS) and/or local peptide
sequence that is poorly gripped by the unfoldase (DnaX) appear
to release the protein from the grasp of the unfoldase, thereby
attenuating or preventing degradation. Both of these types of
elements also delimit the degraded region in two transcription
factors that are processed by the 26S proteasome (Tian et al.,
2005). Limited unfolding and translocation of ALAS by mtClpX,
such as we propose, may be dictated by similar sequence
and/or structural elements within ALAS. Defining this signal will
help to delineate an emerging set of rules by which the fates of
AAA+ unfoldase and protease substrates are determined.
EXPERIMENTAL PROCEDURES
Statistics
Error bars indicate SD, calculated from at least three biological replicates. The
p values were calculated using Student’s t test, unless otherwise indicated.
Yeast Strain Construction and Culture
Strains used in this study are listed in Table S1. Yeast genes were modified at
chromosomal loci using standard homologous recombination techniques.
Yeast strains were grown for experimental purposes in synthetic defined
medium (YNB + CSM [yeast nitrogen base plus complete supplement
mixture], Sunrise Sciences) with 2% dextrose at 30C with shaking, unless
otherwise indicated.
Heme and ALA Measurement
Cellular heme levels weremonitored by porphyrin fluorescence and 55Fe label-
ing. ALA levels in cell extracts were quantified using modified Ehrlich’s
reagent. ALA production by purified proteins was quantified using modified
Ehrlich’s reagent or by a NAD-coupled assay as indicated. See Extended
Experimental Procedures for details.
Metabolic Profiling
Metabolite extracts were made by rapid vacuum filtration of yeast liquid
culture, followed by incubation of the cell-laden filter in extraction solventCell 161, 858–867, May 7, 2015 ª2015 Elsevier Inc. 865
(40% acetonitrile, 40%methanol, 20%water). Extracts were analyzed for rela-
tive metabolite levels by LC-MS. See Extended Experimental Procedures for
further details.
Protein Purification and Biochemical Assays
mtClpX, mtClpP, and ALAS proteins were recombinantly produced in their
mature forms (lacking the mitochondrial presequence). Biochemical assays
for ALAS activity and PLP reconstitution were performed at 30C in 25 mM
HEPES (pH 7.6), 5 mMMgCl2, and 10%glycerol with ATP regenerating system
(5 mM creatine phosphate and 50mg/ml creatine kinase, with 2 mMATPwhen
indicated), supplemented with 100 mM KCl (Hem1) or 130 mM KCl and
0.75 mg/ml BSA (ALAS2). 50 mM PLP was included in reconstitution experi-
ments. Protein concentrations during PLP reconstitution were as follows:
3 mM apoHem1, 2 mM Mcx1 (hexamer), 5 mM apoALAS2, 2 mM mouse ClpX
(hexamer), 3 mM human ClpP-His6 (14-mer). For detailed procedures, see
Extended Experimental Procedures.
Zebrafish Maintenance and Studies
Wild-type (AB), dino (dintt250) (Hammerschmidt et al., 1996), and Tg(globin-
LCR:eGFP) (Ganis et al., 2012) zebrafish (Danio rerio) were maintained, bred,
and staged according to standard methods (Lawrence et al., 2003). Zebrafish
studies were conducted with the approval of the Institutional Animal Care and
Use Committee at Boston Children’s Hospital. Embryos were stained for he-
moglobinized cells with o-dianisidine as previously described (Amigo et al.,
2009). Flow cytometry was used to quantify erythrocytes from embryos (Coo-
ney et al., 2013).
Morpholino-Mediated Knockdown in Zebrafish
Splice site-blocking antisense morpholino oligomers (Table S2) were injected
into one- and two-cell-stage embryos. Knockdown in morphant embryos was
confirmed with real-time qRT-PCR using Taqman probes (Applied Bio-
systems). For details of ALA complementation, see Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2015.04.017.
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